drugset / Trial / NCT04728581

Improving Sleep After TKA Using Mirtazapine and Quetiapine

NCT04728581

Not yet recruiting 165 enrolled St. Anna Ziekenhuis, Geldrop, Netherlands
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Use of mirtazapine and quetiapine for improvement of sleep quality after TKA

Timeline

Start
2024-01-01
Primary completion
2026-05-01
Completion
2027-01-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Mirtazapine Other / unclassified 7.5 mg
Subject Quetiapine Small molecule 6.25 mg